Diploma PLC (LON:DPLM – Get Free Report)’s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 6,577.47 and traded as high as GBX 7,212.50. Diploma shares last traded at GBX 7,180.57, with a volume of 391,966 shares trading hands.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. Royal Bank Of Canada raised their price objective on shares of Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a report on Friday, July 17th. Jefferies Financial Group restated a “hold” rating and issued a GBX 7,000 target price on shares of Diploma in a report on Friday, May 29th. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 9,000 target price on shares of Diploma in a research report on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the company a “buy” rating in a research report on Wednesday, May 20th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 7,044.29.
Read Our Latest Report on DPLM
Diploma Price Performance
Insiders Place Their Bets
In other news, insider Mandy Gradden acquired 1,000 shares of Diploma stock in a transaction on Friday, July 17th. The stock was bought at an average price of GBX 7,183 per share, for a total transaction of £71,830. Also, insider Katie Bickerstaffe acquired 133 shares of Diploma stock in a transaction on Thursday, July 16th. The stock was purchased at an average price of GBX 7,048 per share, with a total value of £9,373.84. Insiders have bought a total of 1,604 shares of company stock valued at $11,447,718 over the last quarter. Company insiders own 1.14% of the company’s stock.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
- Five stocks we like better than Diploma
- 3 Low-P/E Stocks That Look Cheap as the S&P 500 Trades Near Record Highs
- Travel + Leisure Goes Big—Is It Ready to Rally?
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
